Establishing comparable requirements and treatment groups before applying statistical comparison-reply
JAMA Neurol
.
2014 Mar;71(3):371-2.
doi: 10.1001/jamaneurol.2013.6003.
Authors
Saurav Chatterjee
1
,
Partha Sardar
2
,
Giuseppe Biondi-Zoccai
3
,
Dharam J Kumbhani
4
Affiliations
1
Division of Cardiology, St Lukes-Roosevelt Hospital, Mount Sinai Health System, New York, New York.
2
Department of Medicine, New York Medical College-Metropolitan Hospital Center, New York, New York.
3
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
4
Division of Cardiology, University of Texas Southwestern, Dallas, Texas.
PMID:
24614993
DOI:
10.1001/jamaneurol.2013.6003
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Anticoagulants / adverse effects*
Atrial Fibrillation / drug therapy*
Humans
Intracranial Hemorrhages / chemically induced*
Substances
Anticoagulants